Chinese Journal of Antituberculosis ›› 2018, Vol. 40 ›› Issue (5): 512-518.doi: 10.3969/j.issn.1000-6621.2018.05.014
• Original Articles • Previous Articles Next Articles
Fei-yong RAN,Lei FU,Bin WANG,Shao-chen GUO,Yu LU(),Xiao-you CHEN(
)
Received:
2018-03-15
Online:
2018-05-10
Published:
2018-06-12
Contact:
Yu LU,Xiao-you CHEN
E-mail:luyu4876@hotmail.com;chenxy1998@hotmail.com
Fei-yong RAN,Lei FU,Bin WANG,Shao-chen GUO,Yu LU,Xiao-you CHEN. Evaluation of the effect of vitamin D on adjuvant therapy in the Guinea Pig model of tuberculosis[J]. Chinese Journal of Antituberculosis, 2018, 40(5): 512-518. doi: 10.3969/j.issn.1000-6621.2018.05.014
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2018.05.014
组别 | 体质量(g, | 8周平均增加 体质量(g) | ||
---|---|---|---|---|
0周 | 4周 | 8周 | ||
空白对照组 | 513.30±49.85 | 639.64±87.02 | 720.82±101.2 | 207.52 |
VD组 | 487.60±16.04 | 602.98±23.04 | 682.37±38.30 | 194.77 |
VDH组 | 504.28±36.89 | 594.13±51.30 | 779.91±86.79 | 275.63 |
H-R组 | 493.70±27.16 | 586.90±58.89 | 649.36±63.01 | 155.66 |
H-R+VD组 | 464.84±38.75 | 541.49±39.29 | 677.85±29.83 | 213.01 |
H-R+VDH组 | 483.23±44.22 | 554.89±50.42 | 703.81±110.50 | 220.58 |
分组 | 肺脏活菌计数(lgCFU, | 脾脏活菌计数(lgCFU, | |||
---|---|---|---|---|---|
4周 | 8周 | 4周 | 8周 | ||
空白对照组 | 5.24±0.14 | 4.45±0.17 | 4.96±0.17 | 5.16±0.34 | |
VD组 | 5.19±0.28 | 4.39±0.20 | 5.39±0.32 | 4.75±0.03 | |
VDH组 | 4.94±0.05 | 4.40±0.14 | 5.85±0.29 | 4.77±0.12 | |
H-R组 | 4.98±0.26 | 3.73±0.23 | 4.02±0.03 | 2.26±0.24 | |
H-R+VD组 | 4.88±0.05 | 3.36±0.43 | 2.36±0.10 | 2.14±0.20 | |
H-R+VDH组 | 4.39±0.11 | 3.21±0.23 | 2.30±0.43 | - |
[1] | World Health Organization . Global tuberculosis report 2017. Geneva: World Health Organization, 2017. |
[2] | World Health Organization . The use of bedaquiline in the treatment of multidrug-resistant tuberculosis: interim policy guidance. Geneva:World Health Organization, 2013. |
[3] |
Fox GJ, Menzies D . A Review of the Evidence for Using Bedaquiline (TMC207)to Treat Multi—Drug Resistant Tuberculosis. Infect Dis Ther, 2013,2(2):123-144.
doi: 10.1007/s40121-013-0009-3 URL |
[4] | World Health Organization . Interim policy guidance for the use of delamanid in the treatment of MDR-TB. Geneva: World Health Organization, 2014. |
[5] |
Gler M, Skripconoka V, Sanche-Garavito E , et al. Delamanid for multidrug-resistant pulmonary tuberculosis. N Engl J Med, 2012,366(23):2151-2160.
doi: 10.1056/NEJMoa1112433 URL pmid: 22670901 |
[6] |
Charpy J, Dowling GB . Vitamin D in cutaneous tuberculosis. Lancet, 1947,2(6472):398.
doi: 10.1590/abd1806-4841.20142998 URL pmid: 20263553 |
[7] |
Daley P, Jagannathan V, John KR , et al. Adjunctive vitamin D for treatment of active tuberculosis in India:a randomised,double-blind,placebo-controlled trial. Lancet Infect Dis, 2015,15(5):528-534.
doi: 10.1016/S1473-3099(15)70053-8 URL |
[8] |
Tukvadze N, Sanikidze E, Kipiani M , et al. High-dose vitamin D3 in adults with pulmonary tuberculosis:a double-blind randomized controlled trial. Am J Clin Nutr, 2015,102(5):1059-1069.
doi: 10.3945/ajcn.115.113886 URL |
[9] |
Ralph AP, Waramori G, Pontororing GJ , et al. L-arginine and Vitamin D Adjunctive Therapies in Pulmonary Tuberculosis:A Randomised,Double-Blind,Placebo-Controlled Trial. PLoS One, 2013,8(8):e70032.
doi: 10.1371/journal.pone.0070032 URL |
[10] |
Salahuddin N, Ali F, Hasan Z , et al. Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized,placebo-controlled,clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis. BMC Infect Dis, 2013,13:22.
doi: 10.1186/1471-2334-13-22 URL |
[11] |
Mily A, Rekha RS, Kamal SMM , et al. Significant Effects of Oral Phenylbutyrate and Vitamin D3 Adjunctive Therapy in Pulmonary Tuberculosis:A Randomized Controlled Trial. PLoS One, 2015,10(9):e0138340.
doi: 10.1371/journal.pone.0138340 URL |
[12] | McCullough PJ, Lehrer DS . Vitamin D,cod liver oil,sunshine, and phototherapy:Safe,effective and forgotten tools for treating and curing tuberculosis infections-A comprehensive review. J Steroid Biochem Mol Biol, 2017,177:21-29. |
[13] |
Pierrot-Deseilligny C, Souberbielle JC . Vitamin D and multiple sclerosis:An update. Mult Scler Relat Disord, 2017,14:35-45.
doi: 10.15586/codon.multiplesclerosis.2017.ch5 URL |
[14] |
Luong KV, Nguyen LT, Nguyen DN . The role of vitamin D in protecting type 1 diabetes mellitus. Diabetes Metab Res Rev, 2005,21(4):338-346.
doi: 10.1007/s11661-999-0313-4 URL pmid: 15852446 |
[15] |
Tagliabue E, Raimondi S, Gandini S. Vitamin D, Cancer Risk , and Mortality. Adv Food Nutr Res, 2015,75:1-52.
doi: 10.1016/bs.afnr.2015.06.003 URL |
[16] |
Abe E, Miyaura C, Sakaqami H , et al. Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA, 1981,78(8):4990-4994.
doi: 10.1073/pnas.78.8.4990 URL |
[17] |
Abe E, Miyaura C, Tanaka H , et al. 1 alpha,25-dihydroxyvitamin D3 promotes fusion of mouse alveolar macrophages both by a direct mechanism and by a spleen cell-mediated indirect mechanism. Proc Natl Acad Sci USA, 1983,80(18):5583-5587.
doi: 10.1073/pnas.80.18.5583 URL |
[18] | Koeffler HP, Amatruda T, Ikekawa N , et al. Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25 dihydroxyvitamin D3 and its fluorinated analogues. Cancer Res, 1984,44(12 Pt1):5624-5628. |
[19] |
Chesdachai S, Zughaier SM, Hao L , et al. The effects of first-line anti-tuberculosis drugs on the actions of vitamin D in human macrophages. J Clin Transl Endocrinol, 2016,6:23-29.
doi: 10.1016/j.jcte.2016.08.005 URL |
[20] |
Reich KM, Fedorak RN, Madsen K , et al. Vitamin D improves inflammatory bowel disease outcomes:Basic science and clinical review. World J Gastroenterol, 2014,20(17):4934-4947.
doi: 10.3748/wjg.v20.i17.4934 URL pmid: 4009525 |
[21] |
Cantorna MT, Snyder L, Lin YD , et al. Vitamin D and 1,25(OH)2D Regulation of T cells. Nutrients, 2015,7(4):3011-3021.
doi: 10.3390/nu7043011 URL pmid: 25912039 |
[22] |
Reeme AE, Robinson RT . Dietary Vitamin D3 Suppresses Pulmonary Immunopathology Associated with Late-Stage Tuberculosis in C3HeB/FeJ Mice. J Immunol, 2016,196(3):1293-1304.
doi: 10.4049/jimmunol.1500931 URL |
[23] |
Zhao X, Yuan Y, Lin Y , et al. Vitamin D status in tuberculosis patients with diabetes,prediabetes and normal blood glucose in China:a cross-sectional study. BMJ Open, 2017,7(9):e017557.
doi: 10.1136/bmjopen-2017-017557 URL |
[24] |
Huang L, Liu C, Liao G , et al. Vitamin D Receptor Gene FokI Polymorphism Contributes to Increasing the Risk of Tuberculosis:An Update Meta-Analysis. Medicine (Baltimore), 2015,94(51):e2256.
doi: 10.1097/MD.0000000000002256 URL pmid: 26705207 |
[25] |
Lee YH, Song GG . Vitamin D receptor gene FokI,TaqI,BsmI,and ApaI polymorphisms and susceptibility to pulmonary tuberculosis:a meta-analysis. Genet Mol Res, 2015,14(3):9118-9129.
doi: 10.4238/2015.August.7.21 URL |
[26] |
Cegielski P, Vernon A . Tuberculosis and vitamin D:what’s the rest of the story. Lancet Infect Dis, 2015,15(5):489-490.
doi: 10.1016/S1473-3099(15)70163-5 URL pmid: 25863560 |
[27] |
Orme IM, Ordway DJ . Mouse and guinea pig models of tuberculosis. Microbiol Spectr, 2016,4(4):1-2.
doi: 10.1128/microbiolspec.TBTB2-0002-2015 URL pmid: 27726797 |
[28] |
Sarathi P, Karethimmaiah H, Goel A . High-dose Vitamin D Supplementation Precipitating Hypercalcemic Crisis in Granulomatous Disorders. Indian J Endocrinol Metab, 2017,21(6):815-819.
doi: 10.4103/ijem.IJEM_577_16 URL |
[29] |
Rode AKO, Kongsbak M, HansenMM , et al. Vitamin D Counteracts Mycobacterium tuberculosis-Induced Cathelicidin Downregulation in Dendritic Cells and Allows Th1 Differentiation and IFNγ Secretion. Front Immunol, 2017,8:656.
doi: 10.3389/fimmu.2017.00656 URL |
[1] | Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453. |
[2] | Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459. |
[3] | Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481. |
[4] | Huang Misun, Wu Yaning, Li Guilian, Liu Haican. Research advances of Mycobacterium tuberculosis enrichment technology [J]. Chinese Journal of Antituberculosis, 2025, 47(3): 369-373. |
[5] | Zhang Chao, Yu Xia, Huang Hairong, Liu Wei, Liu Tao. Evaluation of the in vitro antimicrobial effects of sevoflurane on Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(2): 158-163. |
[6] | Liu Ruihua, Sarina , Wang Furong. Interaction between lung cancer and tuberculosis in disease development and progression [J]. Chinese Journal of Antituberculosis, 2025, 47(1): 102-111. |
[7] | Chen Jifei, Huang Lihua, Luo Lanbo, Sui Wenxian, Pang Yu, Liu Aimei. Evaluation the efficacy of tongue swab-based PCR fluorescence probe method for pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(1): 51-60. |
[8] | Lu Hailin, Wang Wenfei, Tao Wenhui, Lin Peicong, Chen Xinchun, Deng Guofang, Xie Shuixiang. Oleic acid upregulates the expression of perilipin 2 enhancing macrophage clearance of Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(1): 72-76. |
[9] | Wang Yilin, Wu Xiao, Pang Yu, Li Shanshan. Immunomodulatory effect of orelabrutinib in host macrophages infected with mycobacterium [J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1063-1068. |
[10] | Palidanguli Abudureheman, Wang Senlu, Gulina Badeerhan, Wang Le, Zulikatiayi Abudula, Wang Xinqi, Maiwulajiang Yimamu, Wang Xijiang. Distribution of Mycobacterium tuberculosis genotypes in Kashgar region and their association with clinical characteristics of pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1077-1082. |
[11] | Xu Chunhua, Zhu Shiyu, Hu Yi, Yi Kehua, Song Canlei, Wang Zichun, Wu Yong, Wang Qing, Yang Qianru, Shen Xin. Analysis of screening effect of recombinant Mycobacterium tuberculosis fusion protein in screening Mycobacterium tuberculosis infection in close contacts of pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 897-902. |
[12] | Zhang Lanyue, Wang Yingchao, Liu Weiyi, Shang Xuetian, Jia Hongyan, Zhu Chuanzhi, Zhang Zongde, Pan Liping. Study on the effect of thiol acetyltransferase mshD on the growth and stress response of Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 935-941. |
[13] | Yu Lan, Chen Shuangshuang, Wang Nenhan, Tian Lili, Zhao Yanfeng, Fan Ruifang, Liu Haican, Li Chuanyou, Dai Xiaowei. Consistency between phenotypic resistance to fluoroquinolones and genetic mutations in rifampicin resistant Mycobacterium tuberculosis strains [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 942-950. |
[14] | He Xiangrong, Chen Hua, Chen Pinru, Liang Feng, Ren Huili, Zhu Jialou, Hu Jinxing, Tan Yaoju. A case report and literature review of Mycobacterium asiaticum pulmonary disease [J]. Chinese Journal of Antituberculosis, 2024, 46(7): 763-769. |
[15] | Zhang Muli, Sun Zhaogang, Cao Tingming, Xie Zhongyao. The value of three proteins in diagnosing Mycobacterium tuberculosis infection [J]. Chinese Journal of Antituberculosis, 2024, 46(7): 808-814. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||